鼠布鲁氏菌 S2 株通过影响 CALR 的泛素化抑制 IRE1/caspase-12/caspase-3 通路介导的小胶质细胞 HMC3 的凋亡。

IF 3.7 2区 生物学 Q2 MICROBIOLOGY
mSphere Pub Date : 2025-02-28 DOI:10.1128/msphere.00941-24
Zhao Wang, Yanbai Wang, Shulong Yang, Zhenhai Wang, Qian Yang
{"title":"鼠布鲁氏菌 S2 株通过影响 CALR 的泛素化抑制 IRE1/caspase-12/caspase-3 通路介导的小胶质细胞 HMC3 的凋亡。","authors":"Zhao Wang, Yanbai Wang, Shulong Yang, Zhenhai Wang, Qian Yang","doi":"10.1128/msphere.00941-24","DOIUrl":null,"url":null,"abstract":"<p><p>Neurobrucellosis represents a severe complication of brucellosis, posing a considerable risk to human health and quality of life. This condition arises from an increased susceptibility to chronic <i>Brucella</i> infection, a significant clinical challenge. One key factor contributing to chronic neurobrucellosis is the regulation of microglial apoptosis by <i>Brucella</i>; however, the exact molecular mechanisms remain largely unresolved. In this study, human microglial clone 3 (HMC3) cells were infected with <i>Brucella suis</i> vaccine strain S2 (<i>B. suis</i> S2) at varying multiplicity of infection (MOI) and durations to assess its effects on the IRE1/caspase-12/caspase-3 signaling pathway. Following the suppression of this pathway by <i>B. suis</i> S2, calreticulin (CALR) was identified through ubiquitin-modified proteomics (data accessible via ProteomeXchange, identifier PXD056006). To further investigate, CALR-overexpression and knockdown HMC3 cell lines were infected with <i>B. suis</i> S2 to elucidate the mechanism by which <i>B. suis</i> S2 inhibits apoptosis in HMC3 cells. In conclusion, our findings demonstrate that <i>B. suis</i> S2 suppresses HMC3 cell apoptosis via the IRE1/caspase-12/caspase-3 pathway by modulating CALR ubiquitination. This study provides a theoretical basis for exploring the mechanisms of neurobrucellosis and offers insights into its clinical treatment.IMPORTANCENeurobrucellosis is a severe complication impacting the central nervous system (CNS) due to neurological deficits caused by <i>Brucella</i>, with primary clinical features including meningitis, encephalitis, brain abscesses, and demyelinating lesions. These nonspecific symptoms often lead to misdiagnosis or delayed diagnosis, increasing the risk of recurrent or chronic neurobrucellosis infections. Consequently, persistent infection and relapse are critical challenges in the clinical management of neurobrucellosis, which are closely linked to <i>Brucella</i>'s survival and replication within microglia. Interestingly, <i>Brucella</i> may inhibit microglia apoptosis by mitigating endoplasmic reticulum (ER) stress, though the precise molecular mechanisms remain largely unexplored. Thus, this study will elucidate the specific mechanisms by which <i>Brucella</i> suppresses microglial apoptosis and provide deeper insights into the molecular pathogenesis and clinical treatment of neurobrucellosis.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0094124"},"PeriodicalIF":3.7000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"<i>Brucella suis</i> S2 strain inhibits IRE1/caspase-12/caspase-3 pathway-mediated apoptosis of microglia HMC3 by affecting the ubiquitination of CALR.\",\"authors\":\"Zhao Wang, Yanbai Wang, Shulong Yang, Zhenhai Wang, Qian Yang\",\"doi\":\"10.1128/msphere.00941-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Neurobrucellosis represents a severe complication of brucellosis, posing a considerable risk to human health and quality of life. This condition arises from an increased susceptibility to chronic <i>Brucella</i> infection, a significant clinical challenge. One key factor contributing to chronic neurobrucellosis is the regulation of microglial apoptosis by <i>Brucella</i>; however, the exact molecular mechanisms remain largely unresolved. In this study, human microglial clone 3 (HMC3) cells were infected with <i>Brucella suis</i> vaccine strain S2 (<i>B. suis</i> S2) at varying multiplicity of infection (MOI) and durations to assess its effects on the IRE1/caspase-12/caspase-3 signaling pathway. Following the suppression of this pathway by <i>B. suis</i> S2, calreticulin (CALR) was identified through ubiquitin-modified proteomics (data accessible via ProteomeXchange, identifier PXD056006). To further investigate, CALR-overexpression and knockdown HMC3 cell lines were infected with <i>B. suis</i> S2 to elucidate the mechanism by which <i>B. suis</i> S2 inhibits apoptosis in HMC3 cells. In conclusion, our findings demonstrate that <i>B. suis</i> S2 suppresses HMC3 cell apoptosis via the IRE1/caspase-12/caspase-3 pathway by modulating CALR ubiquitination. This study provides a theoretical basis for exploring the mechanisms of neurobrucellosis and offers insights into its clinical treatment.IMPORTANCENeurobrucellosis is a severe complication impacting the central nervous system (CNS) due to neurological deficits caused by <i>Brucella</i>, with primary clinical features including meningitis, encephalitis, brain abscesses, and demyelinating lesions. These nonspecific symptoms often lead to misdiagnosis or delayed diagnosis, increasing the risk of recurrent or chronic neurobrucellosis infections. Consequently, persistent infection and relapse are critical challenges in the clinical management of neurobrucellosis, which are closely linked to <i>Brucella</i>'s survival and replication within microglia. Interestingly, <i>Brucella</i> may inhibit microglia apoptosis by mitigating endoplasmic reticulum (ER) stress, though the precise molecular mechanisms remain largely unexplored. Thus, this study will elucidate the specific mechanisms by which <i>Brucella</i> suppresses microglial apoptosis and provide deeper insights into the molecular pathogenesis and clinical treatment of neurobrucellosis.</p>\",\"PeriodicalId\":19052,\"journal\":{\"name\":\"mSphere\",\"volume\":\" \",\"pages\":\"e0094124\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mSphere\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1128/msphere.00941-24\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mSphere","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/msphere.00941-24","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

神经布鲁氏菌病是布鲁氏菌病的一种严重并发症,对人类健康和生活质量构成相当大的威胁。这种疾病是由于对慢性布鲁氏菌感染的易感性增加而引起的,是一项重大的临床挑战。导致慢性神经布鲁氏菌病的一个关键因素是布鲁氏菌对小胶质细胞凋亡的调控;然而,确切的分子机制在很大程度上仍未得到解决。在这项研究中,人类小胶质细胞克隆3(HMC3)细胞以不同的感染倍率(MOI)和持续时间感染了鼠布鲁氏菌疫苗株S2(B. suis S2),以评估其对IRE1/天冬酶-12/天冬酶-3信号通路的影响。在B. suis S2抑制该通路后,通过泛素修饰蛋白质组学鉴定了钙网蛋白(CALR)(可通过ProteomeXchange获取数据,标识符为PXD056006)。为了进一步研究,用 B. suis S2 感染 CALR 表达和敲除的 HMC3 细胞系,以阐明 B. suis S2 抑制 HMC3 细胞凋亡的机制。总之,我们的研究结果表明,B. suis S2通过调节CALR泛素化,通过IRE1/caspase-12/caspase-3途径抑制HMC3细胞凋亡。该研究为探索神经布鲁氏菌病的发病机制提供了理论依据,并为临床治疗提供了启示。重要意义神经布鲁氏菌病是一种影响中枢神经系统(CNS)的严重并发症,是由布鲁氏菌引起的神经功能障碍,主要临床特征包括脑膜炎、脑炎、脑脓肿和脱髓鞘病变。这些非特异性症状往往导致误诊或延误诊断,增加了神经布鲁氏菌病反复感染或慢性感染的风险。因此,持续感染和复发是神经布鲁氏菌病临床治疗的关键挑战,这与布鲁氏菌在小胶质细胞内的生存和复制密切相关。有趣的是,布鲁氏菌可能会通过减轻内质网(ER)压力来抑制小胶质细胞凋亡,但其确切的分子机制在很大程度上仍未得到探索。因此,本研究将阐明布鲁氏菌抑制小胶质细胞凋亡的具体机制,为神经布鲁氏菌病的分子发病机制和临床治疗提供更深入的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Brucella suis S2 strain inhibits IRE1/caspase-12/caspase-3 pathway-mediated apoptosis of microglia HMC3 by affecting the ubiquitination of CALR.

Neurobrucellosis represents a severe complication of brucellosis, posing a considerable risk to human health and quality of life. This condition arises from an increased susceptibility to chronic Brucella infection, a significant clinical challenge. One key factor contributing to chronic neurobrucellosis is the regulation of microglial apoptosis by Brucella; however, the exact molecular mechanisms remain largely unresolved. In this study, human microglial clone 3 (HMC3) cells were infected with Brucella suis vaccine strain S2 (B. suis S2) at varying multiplicity of infection (MOI) and durations to assess its effects on the IRE1/caspase-12/caspase-3 signaling pathway. Following the suppression of this pathway by B. suis S2, calreticulin (CALR) was identified through ubiquitin-modified proteomics (data accessible via ProteomeXchange, identifier PXD056006). To further investigate, CALR-overexpression and knockdown HMC3 cell lines were infected with B. suis S2 to elucidate the mechanism by which B. suis S2 inhibits apoptosis in HMC3 cells. In conclusion, our findings demonstrate that B. suis S2 suppresses HMC3 cell apoptosis via the IRE1/caspase-12/caspase-3 pathway by modulating CALR ubiquitination. This study provides a theoretical basis for exploring the mechanisms of neurobrucellosis and offers insights into its clinical treatment.IMPORTANCENeurobrucellosis is a severe complication impacting the central nervous system (CNS) due to neurological deficits caused by Brucella, with primary clinical features including meningitis, encephalitis, brain abscesses, and demyelinating lesions. These nonspecific symptoms often lead to misdiagnosis or delayed diagnosis, increasing the risk of recurrent or chronic neurobrucellosis infections. Consequently, persistent infection and relapse are critical challenges in the clinical management of neurobrucellosis, which are closely linked to Brucella's survival and replication within microglia. Interestingly, Brucella may inhibit microglia apoptosis by mitigating endoplasmic reticulum (ER) stress, though the precise molecular mechanisms remain largely unexplored. Thus, this study will elucidate the specific mechanisms by which Brucella suppresses microglial apoptosis and provide deeper insights into the molecular pathogenesis and clinical treatment of neurobrucellosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
mSphere
mSphere Immunology and Microbiology-Microbiology
CiteScore
8.50
自引率
2.10%
发文量
192
审稿时长
11 weeks
期刊介绍: mSphere™ is a multi-disciplinary open-access journal that will focus on rapid publication of fundamental contributions to our understanding of microbiology. Its scope will reflect the immense range of fields within the microbial sciences, creating new opportunities for researchers to share findings that are transforming our understanding of human health and disease, ecosystems, neuroscience, agriculture, energy production, climate change, evolution, biogeochemical cycling, and food and drug production. Submissions will be encouraged of all high-quality work that makes fundamental contributions to our understanding of microbiology. mSphere™ will provide streamlined decisions, while carrying on ASM''s tradition for rigorous peer review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信